Deterioration in demand and the business environment caused by COVID-19
First written in FY2020. 7 of 19 entries say "Worsened", first in FY2021-Q2. Latest entry: FY2026.
Nippon Shikizai moved to the "Worse" side of this theme in 2020.
0 other companies' latest entry also says "Reframed".
- FY2026Business constraint risks, including new infectious diseases, reorganizedAnnual report
「If an outbreak of a new infectious disease such as COVID-19 occurs, the Group's business activities may be constrained or order levels may be significantly affected by measures including hygiene management and infection prevention implemented in accordance with guidelines for preventing the spread of infection.」
Even after the impact of COVID-19 has eased, the company has reorganized this as a risk that a future outbreak of a new infectious disease could affect business activities and orders. - FY2025-H1RestatedAnnual report
「During the previous consolidated fiscal year, the COVID-19 infection situation subsided and normalization progressed significantly.」
The company has reaffirmed its view that the impact of COVID-19 has subsided and the business environment has continued to normalize. - FY2025-Q1MitigatedAnnual report
「During the previous consolidated fiscal year, the COVID-19 infection situation subsided and normalization progressed significantly.」
The impact of the pandemic on society and the economy has been significantly reduced, while demand recovery and normalization of the business environment have progressed. - FY2024-Q3MitigatedAnnual report
「In countries overseas as well, lifestyles adapted to the with- and post-COVID era have already become established, and the impact of COVID-19 on daily life and the economy has been significantly reduced.」
The impact of COVID-19 on daily life and the economy has been significantly reduced, lowering the risk of deterioration in demand and the business environment. However, the uncertainty of its impact continues to be noted. - FY2024-Q2RestatedAnnual report
「The impact of COVID-19 remains uncertain and may affect the Group's financial position and operating results in the future.」
Although the pandemic's impact is showing signs of recovery, the company has reaffirmed its policy of continuing to monitor its impact on its financial position and operating results. - FY2024-Q1RestatedAnnual report
「Although signs of recovery from the effects of COVID-19 have emerged, they are difficult to reasonably forecast at this time. We have therefore assumed that the effects will continue through the end of the current consolidated fiscal year and have made accounting estimates concerning impairment of fixed assets and the recoverability of deferred tax assets.」
Although the pandemic's impact is trending toward recovery, accounting estimates continue to be made on the assumption that the impact will persist through the fiscal year-end because a reasonable forecast is difficult. - FY2023The pandemic's impact is easing, but uncertainty remains.Annual report
「Although signs of recovery are visible in the impact of COVID-19, it is difficult to make a reasonable forecast at this time. Accordingly, the company assumes that the impact will continue through the end of the following consolidated fiscal year and makes accounting estimates, including impairment of fixed assets and the recoverability of deferred tax assets.」
Although the impact of the pandemic is showing signs of recovery and easing, accounting estimates are being made on the assumption that the impact will continue through the end of the following consolidated fiscal year. - FY2023-Q3The pandemic's impact is easing, but uncertainty remains.Annual report
「Although the impact of COVID-19 on daily life and the economy has eased, uncertainty about the outlook continues.」
While the impact of the pandemic on daily life and the economy is gradually easing, uncertainty remains regarding the eighth wave and the market recovery. - FY2023-Q2The pandemic's impact is easing, but uncertainty remains.Annual report
「Although the impact of COVID-19 on daily life and the economy has gradually eased, uncertainty about the outlook continues.」
While the impact of the pandemic on economic activity is gradually easing, the company states that uncertainty remains over the possibility of reintroducing measures in response to new variants and the recovery in demand. - FY2023-Q1Signs of recovery have emerged, but the pandemic's impact and uncertainty continue.Annual report
「Within the Group, orders from domestic and overseas cosmetics manufacturers are recovering as the impact of the prolonged COVID-19 pandemic eases. However, the Group remains unable to fully utilise the production capacity achieved through capital investment, including the third-phase expansion of the Tsukuba plant, and is being forced to continue its business activities in a difficult environment.」
Although orders in Japan and overseas are recovering despite the pandemic, production capacity remains underutilised and uncertainty about the market recovery persists. - FY2022WorsenedAnnual report
「Although the impact of COVID-19 is difficult to predict reasonably at this time, it is assumed that the impact will continue through the end of the following consolidated fiscal year.」
The company assumes that the pandemic's impact will continue through the end of the following consolidated fiscal year, and describes the prolonged impact on demand, operations and accounting estimates. - FY2022-Q3WorsenedAnnual report
「Under the Medium-Term Business Strategy Vision (2017-2021), launched in FY2017, the Group has been working to increase production capacity and accelerate globalization. However, the unexpected outbreak and spread of COVID-19 and the prolonged impact have forced it to operate in a challenging environment.」
The pandemic's prolonged impact, combined with sluggish demand and orders, has resulted in continued difficult business conditions involving the underutilisation of expanded production capacity and factory closures. - FY2022-Q2WorsenedAnnual report
「Under the Medium-Term Business Strategy Vision (2017-2021), launched in FY2017, the Group has been working to increase production capacity and accelerate globalization. However, the unexpected outbreak and spread of COVID-19 and the prolonged impact have forced it to operate in a challenging environment.」
The prolonged impact of the pandemic continues to affect business activities across the Group, including the underutilisation of expanded production capacity, declining demand and orders, and factory closures. - FY2022-Q1WorsenedAnnual report
「Revenue was ¥2,088 million, down 14.5% year on year, as the effects of (1) lower consumer demand for makeup products in Japan due to reduced outings and the widespread adoption of mask-wearing as measures against COVID-19, (2) a sharp decline in inbound demand from visitors to Japan, (3) lower orders for overseas products due to the global spread of COVID-19, and (4) the continued postponement of new product planning remained significant. In addition, the French consolidated subsidiary reported lower revenue during the cumulative first quarter consolidated period due to the impact of COVID-19.」
The decline in demand and orders caused by the pandemic continued in Japan and overseas, resulting in a 14.5% year-on-year decrease in consolidated revenue. - FY2021WorsenedAnnual report
「In Japan, in response to the decline in cosmetics demand and the government’s two declarations of a state of emergency, the Group was forced to implement measures including telework and reduced production at domestic production sites and headquarters. At the French site, factory utilization also temporarily fell sharply due to the impact of government-imposed lockdowns, resulting in a significant impact on the Group’s business activities as a whole.」
The impact of the infectious disease extended from a decline in demand to reduced production and telework at domestic sites, and lower utilization at the French site, significantly affecting business activities over the full year. - FY2021-Q3WorsenedAnnual report
「Under these business conditions, in Japan, following the government’s declaration of a state of emergency in April 2020, the Group was forced to implement infection-control measures including telework and temporary production suspensions at domestic production sites and headquarters. At the French site, factory utilization also temporarily fell sharply due to the impact of government-imposed lockdowns, resulting in a significant impact on the Group’s business activities as a whole.」
The impact of the infectious disease extended beyond the decline in demand to telework and temporary production suspensions at domestic sites and headquarters, and lower utilization at the French site, significantly affecting the Group’s business activities as a whole. - FY2021-Q2WorsenedAnnual report
「In Japan, following the government’s declaration of a state of emergency in April 2020, the Group was forced to implement measures including having employees at domestic production sites and headquarters stay home, suspend operations and work from home. At the French site, factory utilization also temporarily fell sharply due to the impact of government-imposed lockdowns, resulting in a significant impact across the Group.」
In addition to the decline in demand due to COVID-19, operational impacts spread during the first half to include employees staying home, business suspensions and telework at domestic sites, and lower utilization at the French site. - FY2021-Q1MaterialisedAnnual report
「Net sales amounted to ¥2,442 million, down 22.2% year on year, as the impact of ① lower domestic demand, including reduced inbound demand due to the state of emergency, calls for people to refrain from going out and a sharp decline in tourists, and lower outbound demand due to the global spread of COVID-19, which reduced orders from Japanese cosmetics manufacturers, and ② lower orders from major overseas cosmetics manufacturers due to the global spread of COVID-19 was substantial, although the French consolidated subsidiary recorded higher sales.」
The decline in domestic and overseas demand and the decrease in orders from domestic and overseas cosmetics manufacturers due to COVID-19 actually occurred in the form of a 22.2% year-on-year decline in consolidated net sales and an operating loss, among other effects. - FY2020First statedAnnual report
「The spread of COVID-19 since the beginning of the year has had a serious impact on the global economy, and uncertainty about future economic conditions continues.」
The Company first disclosed the impact of the COVID-19 pandemic on the global economy and cosmetics market as a standalone risk factor, stating that it affected the slowdown in revenue during the fourth quarter.